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Mortality risk in hemodialysis patients and changes in nutritional Nutritional problems are common among patients
indicators: DOPPS. with end-stage renal disease (ESRD) and are associated
Background. Nutritional status is strongly associated with with higher rates of morbidity and mortality, as describedoutcomes among hemodialysis patients. We analyzed the inde-
in a recent Dialysis Outcomes Quality Initiative (DOQI)pendent predictive value of several readily measured nutritional
[1]. Several anthropomorphic and laboratory measure-indicators, including a modified subjective global assessment
(mSGA), body mass index (BMI), serum albumin, serum creat- ments correlate with nutritional status, although no sin-
inine, normalized protein catabolic rate (nPCR), serum bicar- gle measurement provides a complete and unambiguous
bonate, lymphocyte count, and neutrophil count, using baseline
assessment. Several potential indicators are strongly in-and six-month follow-up measurements.
fluenced by non-nutritional factors such as inflammationMethods. The study sample consisted of 7719 U.S. adult
hemodialysis patients enrolled in the international Dialysis and volume overload, which are common in dialysis pa-
Outcomes and Practice Patterns Study (DOPPS), a prospective tients. The use of a broad panel of putative indicators
observational study that includes a random sample of hemodi- may best facilitate the epidemiologic and clinical assess-alysis patients from 145 dialysis facilities in the United States.
ment of nutritional status [2, 3].Cox regression was used to estimate the relative risk of mortal-
The mortality risks associated with several readily mea-ity associated with differences in measurements at baseline and
six months later. Each analysis was adjusted for age, race, sex, sured nutritional indictors were evaluated, including a
and 15 summary comorbid conditions. modified subjective global assessment (mSGA), body mass
Results. Lower baseline measurements of mSGA, BMI, se-
index (BMI), serum albumin, serum creatinine, normal-rum albumin, serum creatinine, and lymphocyte count were
ized protein catabolic rate (nPCR), and lymphocyte count.independently associated with significantly higher risk of mor-
tality. During six-month follow-up, decreases in BMI, serum Also, the associations between mortality risk and serum
albumin, and serum creatinine were also associated with sig- bicarbonate and neutrophil count were examined, as
nificantly higher mortality risk. The risk of mortality increased these indicators are used often to identify acidosis orwith higher baseline and six-month increases in neutrophil count.
inflammation, respectively. The most important evalua-Conclusions. This study confirms that several readily-mea-
tion looked at the mortality risks associated with longitu-sured nutritional indicators predict mortality among hemodial-
ysis patients and that changes in indicator values over six months dinal changes in selected indicators which have not been
provide additional important prognostic information. Interven- well reported. This study was part of the larger Dialysis
tions that modify these indicators of nutritional status may have
Outcomes and Practice Pattern Study (DOPPS), a longi-an important impact on the survival of hemodialysis patients.
tudinal, observational study of chronic hemodialysis pa-
tients involving nationally representative samples of he-
modialysis facilities and patients from seven countries:
France, Germany, Italy, Japan, Spain, the United King-
dom, and the United States. The details of the study
have been described previously [4].
Key words: albumin, body mass index, creatinine, Dialysis Outcomes
and Practice Patterns Study, end-stage renal disease, hemodialysis, lym-
phocyte, mortality, neutrophil, normalized protein catabolic rate, nutri-
METHODStional status, subjective global assessment.
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Table 1. Modified subjective global assessment (mSGA)
Nutrition status
mSGA variable Normal Moderate Severe
Recent weight loss No recent weight loss 5–10% weight loss in 6 months 10% weight loss in6 months
Visual somatic protein wasting
(provider judgment) None None Cachectic appearance
Loss of appetite (patient reported) None Moderate Extreme
Nausea/vomiting (patient reported) None Moderate Extreme
Energy level (patient reported) Rarely tired Sometimes tired Always tired
Disease burden (patient reported) Good/best possible health Moderate health Bad/worse possible health
Classification rules:
1. “Loss of appetite” and “nausea/vomiting” only count as a single factor.
2. “Energy level” and “disease burden” only count as a single factor.
3. Severely malnourished  at least three factors at the severe malnutrition level.
4. Moderately malnourished  if not severely malnourished, any combination of three factors at the moderate or the severe malnutrition level.
Patients who were lost to follow-up (died or departed Some patients entered the study at onset of ESRD,
while others entered after being on dialysis for severalfrom the facility) were replaced by newly enrolled pa-
tients. Clinical data were collected for each subject at years. Statistical adjustment for patient years of ESRD
prior to their entry into the study was made using leftstudy enrollment and approximately every four months
thereafter. In addition, each patient was asked to com- truncation [6, 7]. Left-truncation allows for description
of the survival experience beginning at the start ofplete a questionnaire that included quality of life and
nutritional history items. ESRD, and under this method patients only contribute
to the study during times when they are actually at risk.Data were collected for several putative nutritional
indicators including BMI, serum albumin, serum creati- All analyses were performed using SAS software (SAS
nine, nPCR, lymphocyte count, and mSGA. In addition, Institute, Cary, NC, USA) [8].
data were collected on neutrophil count and serum bicar- Baseline characteristics were tested using a full sample
bonate as indicators of inflammation and acidosis. BMI of 7719 patients. The six-month longitudinal nutritional
was based on the patients’ post-dialysis weight, and labo- data were available for 3739 patients. This decrease re-
ratory values were based on pre-dialysis measurements. sulted primarily from questionnaires not being returned
The nPCR was determined using the two-point model within 60 days of the desired six-month anniversary of
of urea kinetics published by Depner and Daugirdas [5]: the baseline measurement (29% of all patients with first
nPCR (g/kg/day) C0/[a bKt/V c/(Kt/V)] 0.0168, measurement). Attrition (death, transplantation, and de-
where C0 is the pre-dialysis BUN in mg/dL and Kt/V is parture from a study facility) also reduced the sample
the single-pool estimate of dialysis dose. For patients size (18% of all patients with first measurement). All
who received dialysis three times weekly, appropriate models contained both the six-month longitudinal changes
coefficients (a, b, c) were used, depending on whether and the baseline values for each of the individual nutri-
laboratory measurements were obtained at the beginning, tional parameters except mSGA. Where possible, missing
middle, or end of the week. The mSGA was determined nutritional indicator data were handled by creating a bi-
at baseline for each patient, based on the caregivers’ nary missing data variable. This approach yielded an unbi-
responses to questions about patient weight loss and ased estimate of the effects of nutritional indicators on
physical appearance and on patient responses to ques- mortality. Each putative nutritional indicator was grouped
tions about appetite, nausea, energy level, and disease into quartiles and evaluated in a separate model. In addi-
burden. Table 1 describes how this information was used tion, all indicators were entered in an overall multivariate
to classify patients into one of three mSGA categories: model as continuous variables (except for mSGA, which
normal, moderately, or severely malnourished. was entered as a categorical variable). A P value less
Patient characteristics were summarized using stan- than 0.05 was considered statistically significant.
dard descriptive statistics. Cox regression was used to
estimate the risk of mortality associated with both the
RESULTSbaseline and the six-month change data for the nutri-
tional indicators. All models were adjusted for age, race, Table 2 shows demographic and comorbid characteris-
tics for the patient sample (N 7719). Patient character-sex, time since onset of ESRD (through left truncation),
and 15 summary comorbid conditions that were found to istics were similar to other representative samples of
chronic dialysis patients reported in contemporaneousindependently predict mortality among DOPPS patients
(Table 2). studies [9]. Table 3 summarizes the patients’ nutritional
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Table 2. Summary of patient demographics and comorbidities
Factor Mean (SD)
Age years 60.8 (15.6)
Race % black vs. non-black 34.3
Gender % male 55.3
Time since onset ESRD years 2.1 (3.6)
Cancer (other than skin) % 10.9
Cerebrovascular disease % 18.6
Congestive heart failure % 47.1
Coronary heart disease % 50.2
Diabetes mellitus % 49.1
Dyspnea % 34.4 Fig. 1. Relative risk of mortality and categories of modified subjective
HIV/AIDS % 2.3 global assessment (mSGA). All categories of SGA, demographics, and
Hypertension % 84.8 15 comorbid conditions are shown together in a Cox model. *P  0.05
Lung disease % 14.0 vs. normal category.
Neurological disease % 11.0
Other cardiovascular diseasea % 33.3
Peptic ulcer % 9.0
Peripheral vascular disease % 26.4
Psychiatric disorder % 25.8 the highest quartile. Furthermore, mortality risk signifi-
Recurrent cellulitis/gangrene % 10.3 cantly increased among patients with a decrease in BMI
a Includes cardiac arrest, atrial fibrillation, other arrhythmia, permanent pace- of greater than 3.5% (Fig. 2B). A 3.5% decrease in BMI
maker implanted, pericarditis, prosthetic heart valve (s/p valve replacement)
reflects a 3.5% loss in body weight.
A strong inverse association was observed between
mortality and the serum albumin concentration (Fig.
Table 3. Summary of putative nutritional indicators 3A). The relationship did not appear to reach a plateau
even in the range of relatively normal albumin concen-Nutritional indicator Mean (SD)
trations, as shown by the significant differences in riskModerate malnutrition % 7.6 (26.6)
between the third and fourth quartiles. Mortality riskSevere malnutrition % 11.0 (31.3)
Baseline BMI kg/m2 25.4 (5.9) also was strongly associated with a decline in the serum
Height m 1.7 (0.11) albumin concentration during the six-month follow-upPost-dialysis weight kg 73.1 (19.7)
(Fig. 3B). A decline in the serum albumin concentrationBaseline albumin g/dL 3.6 (0.6)
Baseline creatinine mg/dL 8.8 (3.7) of greater than 5.3% was associated with a near doubling
Baseline nPCR 1.0 (0.3) of mortality risk (P  0.001).Baseline lymphocyte cells/mm3 1494.4 (1314.5)
Mortality risk also was inversely associated with theBaseline bicarbonate mEq/L 20.9 (4.2)
Baseline neutrophil cells/mm3 5287.4 (2752.2) baseline serum creatinine concentration (Fig. 4A) and a
BMI % 2.2 (7.9) decrease in the serum creatinine concentration (Fig. 4B).
Albumin % 8.8 (16.7)
In both cases, the mortality risk was 60 to 70% higherCreatinine % 17.4 (33.3)
nPCR % 7.6 (33.8) in the lowest quartile group compared with the highest
Lymphocyte % 21.5 (33.6) quartile group.
Bicarbonate % 3.3 (24.6)
The lowest quartile of baseline lymphocyte count wasNeutrophil % 14.3 (26.9)
associated with increased risk of mortality, but a six-
month change in lymphocyte count was not significantly
related to death risk (Fig. 5). In contrast, mortality in-
creased in association with higher baseline neutrophilcharacteristics and changes () during the six-month fol-
low-up. The restricted sample (N 3739) used to analyze count and longitudinal increases in the neutrophil count
(Fig. 6). A strong inverse correlation was observed be-the impact of changes in the putative nutritional indica-
tors was similar to the larger sample in all respects (data tween neutrophil count and serum albumin (R0.206,
P  0.0001) and between neutrophil count and serumnot shown).
Patients with severely malnourished mSGA scores had creatinine (R2  0.172, P  0.0001).
There was no association between mortality and base-a 33% higher mortality risk, and patients with moderate
malnutrition had a 5% higher mortality risk than patients line measurements of nPCR. A large six-month decline
in nPCR (15.6%) was associated with higher mortalitywith normal mSGA scores (Fig. 1). Unlike other putative
indicators, mSGA was not measured longitudinally, as (RR  1.22), but this finding was not statistically signifi-
cant (not shown). For serum bicarbonate concentration,these data were not available at the six-month follow-up.
Mortality risk was higher for patients with lower BMI, there was no association between mortality and either
the baseline level or six-month change (data not shown).and there was no indication of increased risk associated
with obesity (Fig. 2A). Patients in the lowest BMI quartile Table 4 displays the results of the individual models
for each indicator as a continuous variable, except forhad a mortality risk 60% higher than that of patients in
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Fig. 2. Relative risk of mortality and quartiles
of body mass index (BMI), adjusted for base-
line BMI (A), BMI (B), demographics, and
15 comorbid conditions. *P  0.05 and †P 
0.001 vs. 4th quartile.
Fig. 3. Relative risk of mortality and quartiles
of serum albumin, adjusted for baseline albu-
min (A), albumin (B), demographics, and 15
comorbid conditions. *P  0.05 and †P 
0.001 vs. 4th quartile.
mSGA, which is a categorical variable. Each model was nutrition. The results illustrate the potential value of using
a variety of measures to assess nutritional status in epide-adjusted for the factors listed in Table 2. The results
miological studies and, potentially, for clinical evalua-of an overall Cox regression model that simultaneously
tion. A major strength of this study is the longitudinalincluded all nutritional indicators entered as continuous
measurements of nutritional data for a large, representa-variables (except for mSGA) is shown in the right col-
tive sample of hemodialysis patients in the United States.umn. In the overall model, significant associations per-
Although nutritional status was not independently cor-sisted between mortality and BMI, serum albumin, six-
roborated, the validity of the results is partly affirmedmonth change in albumin, serum creatinine, neutrophil
by the strength of the associations between mortalitycount, and mSGA.
and putative nutritional indicators. Furthermore, several
associations observed in this study have been described
DISCUSSION previously in ESRD patients.
This study investigated the impact of several putative Mortality risk was significantly associated with mSGA.
nutritional indicators on mortality in chronic hemodialy- The mSGA is based on subjective and objective aspects
sis patients. Mortality risk was significantly associated of the patients’ medical history and physical examina-
tion, including any recent weight loss, dietary intake,with clinical measurements that are possibly linked to
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Fig. 4. Relative risk of mortality and quartiles
of serum creatinine, adjusted for baseline cre-
atinine (A), creatinine (B), demographics,
and 15 comorbid conditions. *P  0.05 and
†P  0.001 vs. 4th quartile.
Fig. 5. Relative risk of mortality and quartiles
of lymphocyte count, adjusted for baseline
lymphocyte count (A), lymphocyte count (B),
demographics, and 15 comorbid conditions.
*P  0.05 vs. 4th quartile.
Fig. 6. Relative risk of mortality and quartiles
of neutrophil count, adjusted for neutrophil
count (A),neutrophil count (B), demograph-
ics, and 15 comorbid conditions. *P  0.05
and †P  0.001 vs. 4th quartile.
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Table 4. Adjusted relative risk (RR) for mortality by nutritional eral population. It has been speculated that this protec-
indicators as continuous variables
tive effect may be due to the benefits of greater energy
Overall reserves if hemodialysis adds to catabolism [13].
Nutritional indicator Isolated multivariate Serum albumin is a marker of visceral protein stores.(vs. reference group or per one SD increase) modelsa modela
However, serum albumin is affected also by non-nutri-
Severe SGA vs. normal 1.33b 1.25b
tional factors such as infection or inflammation, hydra-Moderate SGA vs. normal 1.05 0.97
BMI per 5.9 kg/m2 0.81c 0.88c tion status, and anabolic or catabolic processes [17, 18].
BMI per 10% 0.89 1.02 Nonetheless, we found a significant inverse association
Albumin per 0.56 g/dL 0.74c 0.78c
between mortality and both baseline measures and longi-Albumin per 20% 0.75c 0.76c
Creatinine per 3.7 mg/dL 0.78c 0.85c tudinal change in serum albumin concentration, consis-
Creatinine per 39% 0.88 0.92 tent with findings in other studies [19–23]. The strong
nPCR per 0.28 units 1.02 NA
association between mortality and albumin persisted innPCR per 34% 0.98 NA
Lymphocyte count per 1300 cells/mm3 0.98 0.95 the model that included all the nutritional variables that
Lymphocyte count per 34% 0.99 0.93 we studied (Table 4). Despite its limitations, albumin is
Bicarbonate per 4.2 mEq/L 0.97 NA
a potent and robust indicator of both nutritional statusBicarbonate per 25% 0.97 NA
Neutrophil count per 2800 cells/mm3 1.26c 1.09b and mortality risk.
Neutrophil count per 27% 1.00 1.0 The serum creatinine concentration is related to nutri-
NA, did not significantly predict mortality in Overall Model. tional status in that it reflects somatic protein stores,
a All models adjusted for age, race, sex, duration of ESRD, and 15 comorbid
muscle mass, and dietary protein intake. However, manyfactors
b P  0.05, cP  0.001 other factors influence the serum creatinine concentra-
tion, including age, sex, race, dialysis dose, and residual
renal function [24]. In any case, low serum creatinine
levels have been shown to be highly predictive of future
gastrointestinal symptoms, and a visual assessment of
mortality in dialysis patients [19, 23, 25], as confirmed
subcutaneous fat [10–12]. For this study, we developed
in this study. We also found that mortality risk was associ-
a modified mSGA scoring system (Table 1) based on ated with a fall in the serum creatinine concentration
information provided on standardized questionnaires by over six months. Although not yet used for this purpose,
the nurse study coordinators and the patients. Given its baseline and longitudinal measures of serum creatinine
strong association with mortality, it appears that mSGA concentration could be helpful as clinical indicators of
provides a meaningful assessment of nutritional status. high-risk patients.
This simple and inexpensive indicator could be useful Nutritional and inflammatory status can influence the
for identifying high-risk patients who might benefit from concentrations of various white blood cells. It also has
nutritional interventions. been shown that lymphocyte proliferation and function
Anthropometric measurements are frequently used to are impaired by protein and calorie malnutrition [26].
indicate protein-energy nutritional status. BMI provides In this study, an increased mortality risk was associated
a simple and inexpensive proxy for body mass adjusted with a low baseline lymphocyte count. Mortality risk was
for height. Hence, it provides a more accurate measure not associated with changes in lymphocyte count over
of overweight and obesity than relying on weight alone. six months, however. Owen and Lowrie also reported a
The following BMI guidelines were set by the World strong, inverse relationship between total lymphocyte
Health Organization for the general population: normal count and the risk of death [23]. The association between
(BMI 18 to 25), overweight (BMI25), and obese (BMI lymphocyte count and mortality could be explained by
30). However, there are limitations associated with nutritional or immunological mechanisms.
BMI, especially its inability to differentiate between Infectious and inflammatory processes are stimuli of
bone, muscle, and fat compartments. In addition, BMI neutrophil proliferation. In our study, risk of mortality
may be misleading in the presence of edema, which is was directly associated with both the neutrophil count at
commonly present in the hemodialysis population. De- baseline and with six-month increases in the neutrophil
spite these limitations, many studies have shown BMI count. These findings suggest that the presence of an
to be highly correlated with both morbidity and mortality infection or inflammatory response, as indicated by a
[13–16]. In our analyses using post-dialysis weight of high or rising neutrophil count, is associated with higher
patients for BMI calculations, we observed a significantly mortality. Furthermore, we observed a strong inverse
higher risk of mortality in patients with a lower BMI at correlation between neutrophil count and serum albumin
baseline. Furthermore, a large decrease in BMI over and creatinine, consistent with previous studies [23].
six months also was associated with increased risk of These findings suggest that infection or inflammation
mortality. A high BMI seems to have a protective effect has a potentially negative effect on serum albumin and
creatinine, causing decreased levels of these nutritionalfor chronic hemodialysis patients, in contrast to the gen-
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